Product Information

CLORAZEPATE 3.75 MG TABLET is a generic product labeled by Apotex Corp., priced at $0.6006 per EA under NDC 60505475401. Its NADAC has been published 203 times since Jan 4, 2023.

FDA first approved this application on Jun 14, 2022. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

CLORAZEPATE 3.75 MG TABLET

Clorazepate Dipotassium
$0.6006per EA
DEA Schedule CIV

Strength

3.75 mg/mg

Manufacturer

Apotex Corp.

NDC

60505475401

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

CLORAZEPATE DIPOTASSIUM

Approval Type

Generic (ANDA)

FDA Application

ANDA215566

FDA Approved

6/14/2022

TE Code

AB

On Market Since

9/22/2022

Pharmacological Classes

Benzodiazepine
Benzodiazepines

Price Statistics

The NADAC for CLORAZEPATE 3.75 MG TABLET has been published 203 times since Jan 4, 2023, and over the history we have for it it has declined 51.8%. The table below summarizes its recorded NADAC range and movement.

Current price$0.6006 per EA
All-time high$1.2455 (Jan 11, 2023)
All-time low$0.5189 (Oct 21, 2026)
52-week high$0.8878
52-week low$0.5189
Median price$0.8004
Average price$0.7825
Largest weekly change+48.9% (Sep 18, 2024)
Weeks tracked203
Tracking sinceJan 4, 2023

Price History

1W

+15.8%

1M

+14.6%

3M

+3.3%

6M

-4.7%

1Y

-30.9%

3Y

-14.3%

5Y

N/A

All

-51.8%

Generic Alternatives

The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of CLORAZEPATE 3.75 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for CLORAZEPATE 3.75 MG TABLET, manufactured by Apotex Corp., is $0.6006 per EA (NDC 60505475401), effective Nov 18, 2026.

How has the price of CLORAZEPATE 3.75 MG TABLET changed over time?

Over the history we have for it, the NADAC for CLORAZEPATE 3.75 MG TABLET has declined 51.8%. It has been tracked across 203 weekly CMS publications since Jan 4, 2023.

What are the highest and lowest recorded NADAC prices for CLORAZEPATE 3.75 MG TABLET?

Since Jan 4, 2023, the NADAC for CLORAZEPATE 3.75 MG TABLET has ranged from a low of $0.5189 (Oct 21, 2026) to a high of $1.2455 (Jan 11, 2023), with a median of $0.8004 per EA.

Are there cheaper alternatives to CLORAZEPATE 3.75 MG TABLET?

3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as CLORAZEPATE 3.75 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures CLORAZEPATE 3.75 MG TABLET?

CLORAZEPATE 3.75 MG TABLET (NDC 60505475401) is labeled by Apotex Corp., and CMS classifies it as a generic product.